The COVID-19 pandemic has impacted virtually every aspect of cancer care and research—from introducing new risks for cancer patients to disrupting the delivery of cancer treatment and the continuity of […]
Although it may not be in the cards for many clinical trial sponsors, being able to situate trials at dedicated (or research-only) study sites may provide winning advantages in terms […]
Even in the futuristic universe of the Star Trek franchise, Dr. McCoy, Nurse Chapel, and other “carbon-based units” remain vital to providing healthcare to space-faring crews, while technology remains their […]
If that giant sucking noise you’ve been hearing lately is COVID-19 taking all the oxygen out of the room for studies of non-virus medications or devices sponsored by your firm […]
The U.S. Food and Drug Administration’s (FDA’s) Center for Devices and Radiological Health (CDRH) has met the COVID-19 pandemic head-on with aggressive “regulatory flexibility,” the center says in what amounts […]